Invention Grant
- Patent Title: Safe and effective method of treating psoriasis with anti-IL-23 specific antibody
-
Application No.: US16688178Application Date: 2019-11-19
-
Publication No.: US11548941B2Publication Date: 2023-01-10
- Inventor: Julianty Angsana , Patrick Branigan , Samuel DePrimo , Susan Flavin , Shu Li , Xuejun Liu , Ernesto Munoz , Bruce Randazzo
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agency: Riverside Law LLP
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K39/395 ; A61P17/06 ; A61K45/06
Abstract:
A method of treating psoriasis in a patient by administering an IL-23 specific antibody, e.g., guselkumab, in a clinically proven safe and clinically proven effective amount and the patient achieves PASI90, PASI100 or IGA 0 or 1 score as measured 16, 24, 32, 40 and 48 weeks after initial treatment and the patient achieves higher efficacy than a patient treated with the secukinumab antibody.
Public/Granted literature
- US20200157209A1 Safe and Effective Method of Treating Psoriasis with Anti-IL-23 Specific Antibody Public/Granted day:2020-05-21
Information query
